戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                            Obeticholic acid was approved by the US Food and Drug Administration in 2016 a
2                                   Recently, the first agent was approved by the US Food and Drug Administration for stero
3  QC strain ATCC 49226 was defined as 0.06 to 0.5 mug/ml and was approved by the CLSI Subcommittee on Antimicrobial Suscep
4                                                Flexible BLC was approved by the FDA in 2018 for use in the surveillance s
5                                  The CREST-2 Registry (C2R) was approved by National Institute of Neurological Disorders
6                                                Cabozantinib was approved by the European Medicines Agency and the Federal
7                           Axicabtagene ciloleucel (axi-cel) was approved by the Food and Drug Administration for relapsed
8 retrospective interpretation of prospectively acquired data was approved by the local ethics committee.
9                                                Desmopressin was approved by the Food and Drug Administration (FDA) in 197
10 rtance because a new intranasal formulation of desmopressin was approved by the FDA in 2017.
11                        After external review, a final draft was approved by the Committee for the Governance of Periopera
12                                                   Duvelisib was approved by the Food and Drug Administration for relapsed
13                        Left atrial appendage closure (LAAC) was approved by the U.S. Food and Drug Administration (FDA) a
14 cancers.TRIAL REGISTRATIONPhase I/II protocol (NCT03480152) was approved by the IRB committee of the NIH and the FDA.FUND
15                   Materials and Methods The animal protocol was approved by the institutional animal care and use committ
16                           Trial registry The study protocol was approved by the Ethics Committee of Qom University of Med
17 ubjects provided written informed consent, and the protocol was approved by the university institutional review board.
18 rkflow that has been successful since (177)Lu DOTATATE PRRT was approved by the U.S. Food and Drug Administration.
19                                                Our research was approved by the McGill institutional review board (A04-M4
20 )-targeted oligonucleotide-based drug (nusinersen/Spinraza) was approved by US Food and Drug Administration (FDA) in late
21  Methods This single-institution retrospective cohort study was approved by the institutional review board.
22               Materials and Methods This case-control study was approved by the local research ethics committee.
23           This two-center retrospective observational study was approved by an institutional ethics committee, and the ne
24                Materials and Methods This prospective study was approved by the ethics review board, and informed consent
25                Materials and Methods This prospective study was approved by the Institutional Animal Care and Use Committ
26              Materials and Methods This retrospective study was approved by the institutional board review; written infor
27 terials and Methods This single-center, retrospective study was approved by the institutional review board and compliant
28                           Methods: This retrospective study was approved by the institutional review board and included 3
29 erials and Methods This HIPAA-compliant retrospective study was approved by the institutional review board; the requireme
30              Materials and Methods This retrospective study was approved by the local ethics committee and written inform
31                             Materials and Methods The study was approved by a research ethics committee, and participants
32                             Materials and Methods The study was approved by institutional animal and human studies commit
33                                                   The study was approved by the institutional review board and is Health
34                                                   The study was approved by the institutional review board of Thomas Jeff
35                             Materials and Methods The study was approved by the institutional review board.
36                             Materials and Methods The study was approved by the local Ethics Committee, and all patients
37                             Materials and Methods The study was approved by the local ethics committee.
38                             Materials and Methods The study was approved by the local review board (NL42888.029.13).
39 nt of vitamin D-adjusted PTH reference intervals. The study was approved by the UK Ministry of Defence research ethics co
40                                                   The study was approved by the University IRB.
41                            Materials and Methods This study was approved by the animal care committee.
42                            Materials and Methods This study was approved by the institutional review board and compliant
43                            Materials and Methods This study was approved by the institutional review board, and written i
44 s BC-3781, is a semisynthetic pleuromutilin antibiotic that was approved by the Food and Drug Administration for the trea
45 e (MDV3100) is a second-generation antiandrogenic drug that was approved by the Food and Drug Administration in 2012 to t
46                  Amiodarone is an anti-arrhythmic drug that was approved by the US Food and Drug Administration (FDA) in
47 ipants from a prospective cohort study were included, which was approved by the local ethics board and written informed c
48 s (ASHG) workgroup developed this position statement, which was approved by the ASHG Board in November 2018.
49     Materials and Methods For this prospective study, which was approved by the internal review board, a total of 126 par
50 tion vial (pertuzumab, trastuzumab, and hyaluronidase-zzxf) was approved by the US Food and Drug Administration (FDA) on